Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2023

The global Proliferative Diabetic Retinopathy Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Proliferative Diabetic Retinopathy Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Proliferative Diabetic Retinopathy Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Proliferative Diabetic Retinopathy Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Proliferative Diabetic Retinopathy Therapeutics include Acucela Inc, Aerie Pharmaceuticals Inc, Antisense Therapeutics Ltd, Icon Bioscience Inc, Ohr Pharmaceutical Inc, PanOptica Inc, Ribomic Inc and ThromboGenics NV, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Proliferative Diabetic Retinopathy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proliferative Diabetic Retinopathy Therapeutics.

The Proliferative Diabetic Retinopathy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Proliferative Diabetic Retinopathy Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Proliferative Diabetic Retinopathy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Ocriplasmin

1.2.3 PAN-90806

1.2.4 RBM-008

1.2.5 Squalamine Lactate

1.2.6 THR-687

1.2.7 Others

1.3 Market by Application

1.3.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Home Care

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Perspective (2018-2029)

2.2 Proliferative Diabetic Retinopathy Therapeutics Growth Trends by Region

2.2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Proliferative Diabetic Retinopathy Therapeutics Market Dynamics

2.3.1 Proliferative Diabetic Retinopathy Therapeutics Industry Trends

2.3.2 Proliferative Diabetic Retinopathy Therapeutics Market Drivers

2.3.3 Proliferative Diabetic Retinopathy Therapeutics Market Challenges

2.3.4 Proliferative Diabetic Retinopathy Therapeutics Market Restraints

3.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue

3.1.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Therapeutics Revenue

3.4 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio

3.4.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2022

3.5 Proliferative Diabetic Retinopathy Therapeutics Key Players Head office and Area Served

3.6 Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service

3.7 Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size (2018-2029)

6.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023)

6.4 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size (2018-2029)

7.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023)

7.4 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size (2018-2029)

9.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Acucela Inc

11.1.1 Acucela Inc Company Detail

11.1.2 Acucela Inc Business Overview

11.1.3 Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.1.4 Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.1.5 Acucela Inc Recent Development

11.2 Aerie Pharmaceuticals Inc

11.2.1 Aerie Pharmaceuticals Inc Company Detail

11.2.2 Aerie Pharmaceuticals Inc Business Overview

11.2.3 Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.2.4 Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.2.5 Aerie Pharmaceuticals Inc Recent Development

11.3 Antisense Therapeutics Ltd

11.3.1 Antisense Therapeutics Ltd Company Detail

11.3.2 Antisense Therapeutics Ltd Business Overview

11.3.3 Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Introduction

11.3.4 Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.3.5 Antisense Therapeutics Ltd Recent Development

11.4 Icon Bioscience Inc

11.4.1 Icon Bioscience Inc Company Detail

11.4.2 Icon Bioscience Inc Business Overview

11.4.3 Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.4.4 Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.4.5 Icon Bioscience Inc Recent Development

11.5 Ohr Pharmaceutical Inc

11.5.1 Ohr Pharmaceutical Inc Company Detail

11.5.2 Ohr Pharmaceutical Inc Business Overview

11.5.3 Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.5.4 Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.5.5 Ohr Pharmaceutical Inc Recent Development

11.6 PanOptica Inc

11.6.1 PanOptica Inc Company Detail

11.6.2 PanOptica Inc Business Overview

11.6.3 PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.6.4 PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.6.5 PanOptica Inc Recent Development

11.7 Ribomic Inc

11.7.1 Ribomic Inc Company Detail

11.7.2 Ribomic Inc Business Overview

11.7.3 Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.7.4 Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.7.5 Ribomic Inc Recent Development

11.8 ThromboGenics NV

11.8.1 ThromboGenics NV Company Detail

11.8.2 ThromboGenics NV Business Overview

11.8.3 ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Introduction

11.8.4 ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

11.8.5 ThromboGenics NV Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Ocriplasmin

    Table 3. Key Players of PAN-90806

    Table 4. Key Players of RBM-008

    Table 5. Key Players of Squalamine Lactate

    Table 6. Key Players of THR-687

    Table 7. Key Players of Others

    Table 8. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2018-2023)

    Table 12. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2024-2029)

    Table 14. Proliferative Diabetic Retinopathy Therapeutics Market Trends

    Table 15. Proliferative Diabetic Retinopathy Therapeutics Market Drivers

    Table 16. Proliferative Diabetic Retinopathy Therapeutics Market Challenges

    Table 17. Proliferative Diabetic Retinopathy Therapeutics Market Restraints

    Table 18. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Players (2018-2023)

    Table 20. Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2022)

    Table 21. Ranking of Global Top Proliferative Diabetic Retinopathy Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service

    Table 25. Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2018-2023)

    Table 29. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2024-2029)

    Table 31. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application (2018-2023)

    Table 33. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application (2024-2029)

    Table 35. North America Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 50. Acucela Inc Company Detail

    Table 51. Acucela Inc Business Overview

    Table 52. Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 53. Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 54. Acucela Inc Recent Development

    Table 55. Aerie Pharmaceuticals Inc Company Detail

    Table 56. Aerie Pharmaceuticals Inc Business Overview

    Table 57. Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 58. Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 59. Aerie Pharmaceuticals Inc Recent Development

    Table 60. Antisense Therapeutics Ltd Company Detail

    Table 61. Antisense Therapeutics Ltd Business Overview

    Table 62. Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Product

    Table 63. Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 64. Antisense Therapeutics Ltd Recent Development

    Table 65. Icon Bioscience Inc Company Detail

    Table 66. Icon Bioscience Inc Business Overview

    Table 67. Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 68. Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 69. Icon Bioscience Inc Recent Development

    Table 70. Ohr Pharmaceutical Inc Company Detail

    Table 71. Ohr Pharmaceutical Inc Business Overview

    Table 72. Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 73. Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 74. Ohr Pharmaceutical Inc Recent Development

    Table 75. PanOptica Inc Company Detail

    Table 76. PanOptica Inc Business Overview

    Table 77. PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 78. PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 79. PanOptica Inc Recent Development

    Table 80. Ribomic Inc Company Detail

    Table 81. Ribomic Inc Business Overview

    Table 82. Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Product

    Table 83. Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 84. Ribomic Inc Recent Development

    Table 85. ThromboGenics NV Company Detail

    Table 86. ThromboGenics NV Business Overview

    Table 87. ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Product

    Table 88. ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023) & (US$ Million)

    Table 89. ThromboGenics NV Recent Development

    Table 90. Research Programs/Design for This Report

    Table 91. Key Data Information from Secondary Sources

    Table 92. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Ocriplasmin Features

    Figure 4. PAN-90806 Features

    Figure 5. RBM-008 Features

    Figure 6. Squalamine Lactate Features

    Figure 7. THR-687 Features

    Figure 8. Others Features

    Figure 9. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Application: 2022 VS 2029

    Figure 11. Hospital Case Studies

    Figure 12. Clinic Case Studies

    Figure 13. Home Care Case Studies

    Figure 14. Proliferative Diabetic Retinopathy Therapeutics Report Years Considered

    Figure 15. Global Proliferative Diabetic Retinopathy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 16. Global Proliferative Diabetic Retinopathy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region: 2022 VS 2029

    Figure 18. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Players in 2022

    Figure 19. Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2022)

    Figure 20. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2022

    Figure 21. North America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2018-2029)

    Figure 23. United States Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Canada Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2018-2029)

    Figure 27. Germany Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2018-2029)

    Figure 35. China Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Japan Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. South Korea Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Southeast Asia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. India Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Australia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2018-2029)

    Figure 43. Mexico Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Brazil Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2018-2029)

    Figure 47. Turkey Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Saudi Arabia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Acucela Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 50. Aerie Pharmaceuticals Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 51. Antisense Therapeutics Ltd Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 52. Icon Bioscience Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 53. Ohr Pharmaceutical Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 54. PanOptica Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 55. Ribomic Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 56. ThromboGenics NV Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2018-2023)

    Figure 57. Bottom-up and Top-down Approaches for This Report

    Figure 58. Data Triangulation

    Figure 59. Key Executives Interviewed